E
IMGN

Ergoteles’s Immunogen Inc IMGN Stock Holding History

Ergoteles’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-77,537
Closed -$1.46M – 951
2023
Q2 		$1.46M Buy
+77,537
New +$915K 0.07% 351
2023
Q1 		– Sell
-15,582
Closed -$77.3K – 1912
2022
Q4 		$77.3K Buy
+15,582
New +$84.5K ﹤0.01% 1251
2022
Q1 		– Sell
-128,815
Closed -$956K – 1721
2021
Q4 		$956K Buy
128,815
+86,458
+204% +$537K 0.04% 427
2021
Q3 		$240K Buy
+42,357
New +$245K 0.01% 903

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ergoteles's IMGN Position: Q3 2023 in Review

Ergoteles sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 77,537 shares — an estimated $1.46M sold.

Ergoteles first reported a position in IMGN in Q3 2021 and held it in 4 quarters. The position peaked at $1.46M in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • Ergoteles reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 77,537 Immunogen Inc shares in Q3 2023, an estimated $1.46M.
  • Ergoteles first reported a position in Immunogen Inc in Q3 2021 and held it in 4 quarters.
  • Ergoteles's Immunogen Inc position peaked at $1.46M in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.